[{"orgOrder":0,"company":"Thorne HealthTech","sponsor":"Performance First","pharmaFlowCategory":"DU","therapeuticArea":"Sleep","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Piper Methysticum Extract","moa":"Undisclosed","graph1":"Sleep","graph2":"Undisclosed","graph3":"Thorne HealthTech","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Sleep","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Thorne HealthTech \/ Performance First","highestDevelopmentStatusID":"1","companyTruncated":"Thorne HealthTech \/ Performance First"},{"orgOrder":0,"company":"Thorne HealthTech","sponsor":"Indena","pharmaFlowCategory":"DU","therapeuticArea":"Cardiology\/Vascular Diseases","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2022","type":"Inapplicable","leadProduct":"Quercetin Phytosome","moa":"Undisclosed","graph1":"Cardiology\/Vascular Diseases","graph2":"Undisclosed","graph3":"Thorne HealthTech","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Thorne HealthTech \/ Indena","highestDevelopmentStatusID":"1","companyTruncated":"Thorne HealthTech \/ Indena"},{"orgOrder":0,"company":"Thorne HealthTech","sponsor":"AstraZeneca","pharmaFlowCategory":"D","therapeuticArea":"Technology","country":"U.S.A","productType":"Undisclosed","year":"2022","type":"Collaboration","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Technology","graph2":"Discovery Platform","graph3":"Thorne HealthTech","amount2":0,"highestDevelopmentShortName":"Discovery Platform","therapeuticAreaShortName":"Technology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Thorne HealthTech \/ AstraZeneca","highestDevelopmentStatusID":"3","companyTruncated":"Thorne HealthTech \/ AstraZeneca"}]

Find Clinical Drug Pipeline Developments & Deals by Thorne HealthTech

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : The extended collaboration will see the internalization of Thorne's disease discovery platform into AZ for further evaluation and to gain insight into additional uses for AZ molecules.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Undisclosed

                          August 04, 2022

                          Lead Product(s) : Undisclosed

                          Therapeutic Area : Technology

                          Highest Development Status : Discovery Platform

                          Sponsor : AstraZeneca

                          Deal Size : Undisclosed

                          Deal Type : Collaboration

                          blank

                          02

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : Piper Methysticum Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Sleep.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          May 19, 2022

                          Lead Product(s) : Piper Methysticum Extract

                          Therapeutic Area : Sleep

                          Highest Development Status : Undisclosed

                          Sponsor : Performance First

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          BioJapan
                          Not Confirmed
                          BioJapan
                          Not Confirmed

                          Details : Quercetin Phytosome is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Aging.

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          March 25, 2022

                          Lead Product(s) : Quercetin Phytosome

                          Therapeutic Area : Cardiology/Vascular Diseases

                          Highest Development Status : Undisclosed

                          Sponsor : Indena

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank